Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.
Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...
Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.
2d
Pharmaceutical Technology on MSNWeill Cancer Hub East launches to transform treatmentThe Weill Cancer Hub East, a collaborative initiative formed by Weill Cornell Medicine, Princeton University, The Rockefeller ...
The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.
A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...
A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results